首页>
外国专利>
Treatment strategy for non-responders to 100MG subcutaneous mepolizumab
Treatment strategy for non-responders to 100MG subcutaneous mepolizumab
展开▼
机译:非响应者治疗策略对100毫克皮下甲醇蛋白
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed herein are methods of treating severe glucocorticoid-dependent eosinophilic asthma in a subject whose asthma has been inadequately controlled with subcutaneously-administered mepolizumab. Also provided are methods of predicting responsiveness to anti-IL-5 antibody treatment in a subject having severe glucocorticoid-dependent eosinophilic asthma.
展开▼